InvestorsHub Logo
icon url

dDT

02/23/15 4:04 PM

#559426 RE: dDT #559425

AtriCure EPS in-line, beats on revenue

AtriCure (NASDAQ:ATRC): Q4 EPS of -$0.20 in-line.
Revenue of $29.4M (+34.4% Y/Y) beats by $1.03M.